TCR2 THERAPEUTICS INC. (CIK: 0001750019) EDGAR, Information, Filings... CompaniesBIO.Com

TCR2 THERAPEUTICS INC.

Mailing address
100 BINNEY STREET, CAMBRIDGE, Delaware, 02142
Phone
617-949-5200
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

TCR2 THERAPEUTICS INC. (CIK: 0001750019) is an American company incorporated in the state of Massachusetts. Head office is located at 100 BINNEY STREET, CAMBRIDGE, Massachusetts, 02142. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). TCR2 THERAPEUTICS INC. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
TANG KEVIN C	0001178579	May-03-2023	10 percent owner
TANG CAPITAL PARTNERS LP	0001191935	May-03-2023	10 percent owner
TANG CAPITAL MANAGEMENT LLC	0001232621	May-03-2023	10 percent owner
Tomasello Shawn	0001617239	Dec-15-2022	director
Harrison Rosemary	0001838046	Dec-15-2022	officer: Chief Business & Strategy
Hegde Priti	0001880034	Dec-15-2022	director
Olagunju Peter	0001875057	Nov-17-2022	officer: Chief Technical Officer
Sullivan Eric	0001601797	Jun-27-2022	officer: Chief Financial Officer
Webster Stephen W	0001438421	Dec-10-2020	director
Justice Angela	0001732986	Dec-10-2020	officer: Chief People Officer
Hoos Axel	0001809415	Dec-10-2020	director
F2 BBG LLC	0001767415	Feb-19-2019	10 percent owner
F2 Capital I 2019, LLC	0001767418	Feb-19-2019	10 percent owner
Globeways Holdings II Ltd	0001768161	Feb-19-2019	10 percent owner
GADICKE ANSBERT	0001134655	Feb-13-2019	director, 10 percent owner
EVNIN LUKE	0001134657	Feb-13-2019	10 percent owner
MPM ASSET MANAGEMENT LLC	0001263048	Feb-13-2019	10 percent owner
Baeuerle Patrick	0001362054	Feb-13-2019	director
Allen Andrew R	0001374539	Feb-13-2019	director
Redmile Group, LLC	0001425738	Feb-13-2019	10 percent owner
China Molybdenum Co., Ltd.	0001447960	Feb-13-2019	10 percent owner
Foley Todd	0001473930	Feb-13-2019	10 percent owner
Gibson Neil W	0001555918	Feb-13-2019	director
Menzel Garry E	0001556064	Feb-13-2019	director, officer: President & CEO
Jovan-Embiricos Morana	0001575745	Feb-13-2019	director, 10 percent owner
Finer Mitchell H.	0001578432	Feb-13-2019	director
Globeways Holdings Ltd	0001600769	Feb-13-2019	10 percent owner
MPM BioVentures 2014, L.P.	0001609492	Feb-13-2019	10 percent owner
MPM BioVentures 2014 (B), L.P.	0001609493	Feb-13-2019	10 percent owner
MPM Asset Management Investors BV2014 LLC	0001609495	Feb-13-2019	10 percent owner
Green Jeremy	0001650527	Feb-13-2019	10 percent owner
MPM Oncology Impact Management LP	0001687078	Feb-13-2019	10 percent owner
UBS Oncology Impact Fund L.P.	0001691428	Feb-13-2019	10 percent owner
MPM Oncology Impact Management GP LLC	0001721035	Feb-13-2019	10 percent owner
Oncology Impact Fund (Cayman) Management L.P.	0001721036	Feb-13-2019	10 percent owner
Hofmeister Robert	0001760102	Feb-13-2019	officer: Chief Scientific Officer
Cardama Alfonso Quintas	0001760104	Feb-13-2019	officer: Chief Medical Officer
Somaiya Mayur Ian	0001760303	Feb-13-2019	officer: Chief Financial Officer
MPM BioVentures 2014 LLC	0001765021	Feb-13-2019	10 percent owner
MPM SunStates Fund, L.P.	0001765022	Feb-13-2019	10 percent owner
MPM SunStates GP Managing Member LLC	0001765023	Feb-13-2019	10 percent owner
MPM Asset Management Investors SunStates Fund LLC	0001765025	Feb-13-2019	10 percent owner
MPM SunStates Fund GP LLC	0001765026	Feb-13-2019	10 percent owner
MPM BioVentures 2014 GP LLC	0001765091	Feb-13-2019	10 percent owner
Upnorth Investment Ltd	0001766474	Feb-13-2019	10 percent owner
F2 Bioscience II 2017 Ltd	0001767388	Feb-13-2019	10 percent owner
F2 Captial I 2017 Ltd	0001767390	Feb-13-2019	10 percent owner
F2 Capital I 2015 Ltd	0001767391	Feb-13-2019	10 percent owner
F2 MG Ltd	0001767396	Feb-13-2019	10 percent owner
F2 - TPO Investments LLC	0001767397	Feb-13-2019	10 percent owner
China Molybdenum (Hong Kong) Co Ltd	0001767622	Feb-13-2019	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TCR2 THERAPEUTICS INC.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-003784 ( Act) Size: 9 KB	Feb-14-2024
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001214659-24-002881 (34 Act) Size: 74 KB	Feb-14-2024	005-90936 24637385
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001104659-23-070143 (34 Act) Size: 11 KB	Jun-12-2023	001-38811 231007066
EFFECT	Document	Acc-no: 9999999995-23-001627 (33 Act) Size: 1 KB	Jun-05-2023	333-254355 23994772
EFFECT	Document	Acc-no: 9999999995-23-001626 (33 Act) Size: 1 KB	Jun-05-2023	333-252244 23994770
EFFECT	Document	Acc-no: 9999999995-23-001625 (33 Act) Size: 1 KB	Jun-05-2023	333-236965 23994766
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-034346 ( Act) Size: 9 KB	Jun-05-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-034343 ( Act) Size: 12 KB	Jun-05-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-034340 ( Act) Size: 18 KB	Jun-05-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-034336 ( Act) Size: 11 KB	Jun-05-2023
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001104659-23-067104 (33 Act) Size: 25 KB	Jun-01-2023	333-254355 23985345
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001104659-23-067103 (33 Act) Size: 25 KB	Jun-01-2023	333-252244 23985333
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001104659-23-067102 (33 Act) Size: 25 KB	Jun-01-2023	333-236965 23985321
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-067098 (33 Act) Size: 27 KB	Jun-01-2023	333-270766 23985315
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-067097 (33 Act) Size: 27 KB	Jun-01-2023	333-263770 23985307
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-067095 (33 Act) Size: 27 KB	Jun-01-2023	333-254354 23985299
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-067092 (33 Act) Size: 27 KB	Jun-01-2023	333-237481 23985285
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-23-067090 (33 Act) Size: 27 KB	Jun-01-2023	333-229691 23985274
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-067082 ( Act) Size: 17 KB	Jun-01-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-067078 ( Act) Size: 13 KB	Jun-01-2023

Recent 20 filings. View all TCR2 THERAPEUTICS INC. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

TCR2 THERAPEUTICS INC. overview
TCR2 THERAPEUTICS INC. job
TCR2 THERAPEUTICS INC. stock
TCR2 THERAPEUTICS INC. ownership
TCR2 THERAPEUTICS INC. CEO
TCR2 THERAPEUTICS INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.